← Leaderboards
Yi Shi
Icahn School Of Medicine At Mount Sinai
$3,269,966
Attributed
$5,237,446
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,237,446 · 3
By mechanism
R01$2,505,945 · 1
R35$2,137,800 · 1
R21$593,701 · 1
Top collaborators
- William Paul Duprex4 shared
- Cheng Zhang4 shared
- Sarah Jane Hainer3 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Viviana A Simon$21,556,427
- Goran Bajic$3,116,277
- Cheng Zhang$6,068,855
- William Paul Duprex$23,556,651
- Hongyan Jenny Zou$7,330,446
Others in their field
Other Emerging Leaders on “Affinity”
- Bala Raja · Luminostics, Inc.$28,624,460
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$25,726,378
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,465,582
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Timothy M Willson · University Of Cape Town$13,865,323
Research focus
AffinityNanobodiesTechnologyProteomicsAntibodiesProductionStructureCostBiomedical EngineeringPharmaceutical PreparationsBindingCohortAntigensImmune ResponseMolecular ConformationSpecificityThermostabilitySolubilityInsightCommunitiesInterestReportingResolutionImmunoglobulin G
Grant awards (13)
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$535,044
R01 · FY2025 · AI · contact PI
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$587,096
R01 · FY2024 · AI · contact PI
Development of the next generation antibody technologies and their applications$422,500
R35 · FY2024 · GM · contact PI
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$614,795
R01 · FY2023 · AI · contact PI
Development of the next generation antibody technologies and their applications$422,500
R35 · FY2023 · GM · contact PI
Using nanobodies to increase the sensitivity and resolution of chromatin profiling through uliCUT&RUN$186,813
R21 · FY2023 · CA
A Shimadzu micro-scale HPLC system for analysis of nanobody repertoires$86,758
R35 · FY2023 · GM · contact PI
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$769,010
R01 · FY2022 · AI · contact PI
Development of the next generation antibody technologies and their applications$422,500
R35 · FY2022 · GM · contact PI
Using nanobodies to increase the sensitivity and resolution of chromatin profiling through uliCUT&RUN$186,813
R21 · FY2022 · CA
Development of the next generation antibody technologies and their applications$392,292
R35 · FY2021 · GM · contact PI
Using nanobodies to increase the sensitivity and resolution of chromatin profiling through uliCUT&RUN$220,075
R21 · FY2021 · CA
Development of the next generation antibody technologies and their applications$391,250
R35 · FY2020 · GM · contact PI